News
Steroids May Obscure Predictive Power of Circulating Biomarkers in Lung Cancer Patients, Study Finds
A recent paper has shed more light on how corticosteroids frequently prescribed to lung cancer patients could inhibit the ...
Can Scientists Develop Drugs for Genetic Diseases by Studying Those Who Should Have Them, But Don't?
Researchers led by the nonprofit 4YouandMe and Mount Sinai want to identify second-site suppressor mutations as drug targets ...
The firm will evaluate its EGFR-targeted ADC ALX2004 in advanced non-small cell lung, head and neck, esophageal, and colorectal cancers.
Precigen had sought accelerated approval for Papzimeos, but the FDA opted to grant it full approval after reviewing data from a Phase I/II trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback